Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.35 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21470305 | 0.90 | GAA (0.44) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470303 | 0.90 | TPSAB1 (0.40) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL26036186 | 0.90 | TPSAB1 (0.38) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470304 | 0.88 | HDAC3 (0.39) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470302 | 0.88 | TPSAB1 (0.38) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470300 | 0.87 | CXCR4 (0.35) | LMNAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL21470151 | 0.87 | TPSAB1 (0.35) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470306 | 0.87 | TPSAB1 (0.37) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL21470301 | 0.85 | MEN1 (0.39) | TPSAB1LMNAMEN1KMT2AGAA | |
| SCHEMBL18222836 | 0.83 | TPSAB1 (0.42) | TPSAB1LMNAMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230330276-A1 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | Clarity Pharmaceuticals Limited (AU) | 2023-10-19 | — | — | US | disclosed |
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | Clarity Pharmaceuticals Limited (AU) | 2023-08-29 | — | — | US | disclosed |
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | Clarity Pharmaceuticals Limited (AU) | 2023-08-29 | — | — | US | disclosed |
| US-20210030900-A1 | TARGETING COMPOUNDS AND METHODS FOR THEIR PRODUCTION | Clarity Pharmaceuticals Ltd (AU) | 2021-02-04 | — | — | US | disclosed |
| US-20210015950-A1 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | Clarity Pharmaceuticals Limited (AU) | 2021-01-21 | — | — | US | disclosed |
| WO-2019195888-A1 | TARGETING COMPOUNDS AND METHODS FOR THEIR PRODUCTION | THE UNIVERSITY OF MELBOURNE (AU) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019195890-A1 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | Clarity Pharmaceuticals Pty Ltd (AU) | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738100-B2 | Formulations and kits for radiotherapy and diagnostic imaging | FOLH1, GGH, CD74 | TPSAB1 301/4885LMNA 3672/4885MEN1 191/4885 |
| US-20210030900-A1 | TARGETING COMPOUNDS AND METHODS FOR THEIR PRODUCTION | TSPO, FOLH1, FABP2 | TPSAB1 167/4885LMNA 1835/4885MEN1 293/4885 |
| US-20210015950-A1 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | FOLH1, GGH, CD74 | TPSAB1 301/4885LMNA 3672/4885MEN1 191/4885 |
| US-20230330276-A1 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | FOLH1, GGH, CD74 | TPSAB1 301/4885LMNA 3672/4885MEN1 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.